PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · IEX Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: Mar 28, 2024, 4:00 PM
1.730
+0.030 (1.76%)
After-hours: Mar 28, 2024, 4:33 PM EDT
PMV Pharmaceuticals Stock Forecast
PMVP's stock price has decreased by -65.02% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PMV Pharmaceuticals stock have an average target of 9.00, with a low estimate of 5.00 and a high estimate of 15. The average target predicts an increase of 429.41% from the current stock price of 1.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PMVP stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +194.12% | Mar 7, 2024 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +311.76% | Dec 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $29 → $5 | Strong Buy | Maintains | $29 → $5 | +194.12% | Oct 16, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $29 | Strong Buy | Maintains | $35 → $29 | +1,605.88% | Aug 11, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +1,958.82% | May 17, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.46
from -1.44
EPS Next Year
-1.61
from -1.46
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 12.3M | 115.3M | 227.3M |
Avg | n/a | n/a | 4.0M | 112.0M | 220.8M |
Low | n/a | n/a | n/a | 107.6M | 212.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 2,797.9% | 103.0% |
Avg | - | - | - | 2,715.2% | 97.2% |
Low | - | - | - | 2,604.6% | 89.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.12 | -1.26 | -1.22 |
Avg | -1.46 | -1.61 | -1.38 |
Low | -1.70 | -2.13 | -1.69 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.